Accelerated in-stent restenosis after bare-metal stenting of a myocardial bridge and successful treatment with drug-eluting stenting.
Stenting of symptomatic myocardial bridges is a therapeutic option with documented good short-term outcome. However, limited data on the long term outcome of myocardial bridge stenting has shown a higher restenosis rate comparing to stenting of de novo atherosclerotic lesions. Drug-eluting stenting of de novo atherosclerotic lesions has reduced the rate of restenosis comparing to bare metal stenting, but there is no available data on drug-eluting myocardial bridge stenting. We present a case of accelerated in-stent restenosis after bare-metal myocardial bridge stenting, successfully treated with drug-eluting stenting.